Highlights and Quick Summary
- Financing cash flow for the quarter ending June 30, 2023 was $24.9 Million (a -13.57% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow increased by 35480.0%
- Annual Financing cash flow for 2022 was $37.4 Million (a -76.31% decrease from previous year)
- Annual Financing cash flow for 2021 was $158 Million (a -58.54% decrease from previous year)
- Annual Financing cash flow for 2020 was $381 Million (a 1804.5% increase from previous year)
- Twelve month Financing cash flow ending June 30, 2023 was $91 Million (a 37.48% increase compared to previous quarter)
- Twelve month trailing Financing cash flow increased by 32868.84% year-over-year
Trailing Financing cash flow for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $91 Million | $66.2 Million | $37.4 Million | $276 Thousand |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Dyne Therapeutics, Inc.
Most recent Financing cash flowof DYN including historical data for past 10 years.Interactive Chart of Financing cash flow of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $24.91 | $28.82 | – | – | – |
| 2022 | $37.2 | $0.07 | $0.1 | $0.02 | $37.39 |
| 2021 | $0.09 | $0.46 | $0.03 | $157.25 | $157.82 |
| 2020 | $-11.19 | $379.98 | $0.0 | $11.91 | $380.69 |
| 2019 | – | – | $0.0 | $19.99 | $19.99 |
| 2018 | – | – | – | – | $12.42 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology